
U.S. Assisted Reproductive Technology Market - Industry Outlook & Forecast 2022-2027
Description
U.S. Assisted Reproductive Technology Market - Industry Outlook & Forecast 2022-2027
The U.S. Assisted Reproductive Technology Market Report contains a Detailed Overview of the Vendor Landscape, Competitive Analysis, And Critical Market Strategies to Gain Competitive Advantage
Increasing prevalence of infertility, rising number of fertility clinics offering fertility services, changing lifestyle of people leading to infertility, increasing acceptance of ART procedure are some of the factors driving the market growth during the forecast period.
The U.S. assisted reproductive technology (ART) market is expected to grow at a CAGR of 6.90% during the forecast period.
GLOBAL U.S. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION
Other factors such as increased number of ART device manufacturing companies, growing investments by private & public players, and increasing financial assistance programs are also contributing to the growth of overall assisted reproductive technology market. However, high cost of infertility treatment and risk associated with in vitro fertilization treatment are expected to restrict the market growth during the forecast period.
Segmentation by Type
The Cooper Companies, Cook Medical and Vitrolife are the major players in the US assisted reproductive technology market. The market also has several regional players that are competing with the global players in terms of new product launch.
The key vendors in the market include the Cooper companies, Cook Medical, FUJIFILM Irvine Scientific, Hamilton Throne, Merck KGaA, and Vitrolife. With the rising demand for infertility treatment in the US, the market share of these vendors is expected to grow in the coming years. However, the major players are facing stiff competition from emerging players.
Vendors are progressively focusing on introducing innovative devices to penetrate and utilize the huge growth potential prevailing in the market. The technological advancements and innovations in the field of ART is providing tremendous growth opportunity to the vendors.
Key Manufacturers Profile
1. The analysis of the U.S. Assisted Reproductive Technology market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the U.S. Assisted Reproductive Technology market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Assisted Reproductive Technology market.
The U.S. Assisted Reproductive Technology Market Report contains a Detailed Overview of the Vendor Landscape, Competitive Analysis, And Critical Market Strategies to Gain Competitive Advantage
Increasing prevalence of infertility, rising number of fertility clinics offering fertility services, changing lifestyle of people leading to infertility, increasing acceptance of ART procedure are some of the factors driving the market growth during the forecast period.
The U.S. assisted reproductive technology (ART) market is expected to grow at a CAGR of 6.90% during the forecast period.
GLOBAL U.S. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION
Other factors such as increased number of ART device manufacturing companies, growing investments by private & public players, and increasing financial assistance programs are also contributing to the growth of overall assisted reproductive technology market. However, high cost of infertility treatment and risk associated with in vitro fertilization treatment are expected to restrict the market growth during the forecast period.
Segmentation by Type
- Services
- Source
- Frozen Non-Donor
- Fresh Non-Donor
- Fresh Donor
- Frozen Donor
- Age Group
- Between 35 & 40 Years
- Less Than 35 Years
- Above 40 Years
- Technique
- In Virto Fertilization (IVF)
- Frozen Embryo Transfer (FET)
- Others
- Devices
- Product
- Consumables
- Media
- Equipment
- End-user
- Fertility Clinics
- Hospitals
The Cooper Companies, Cook Medical and Vitrolife are the major players in the US assisted reproductive technology market. The market also has several regional players that are competing with the global players in terms of new product launch.
The key vendors in the market include the Cooper companies, Cook Medical, FUJIFILM Irvine Scientific, Hamilton Throne, Merck KGaA, and Vitrolife. With the rising demand for infertility treatment in the US, the market share of these vendors is expected to grow in the coming years. However, the major players are facing stiff competition from emerging players.
Vendors are progressively focusing on introducing innovative devices to penetrate and utilize the huge growth potential prevailing in the market. The technological advancements and innovations in the field of ART is providing tremendous growth opportunity to the vendors.
Key Manufacturers Profile
- The Cooper Companies
- Cook Medical
- FUJIFILM Irvine Scientific
- Hamilton Thorne
- Merck Group
- Vitrolife
- CARL ZEISS
- Esco Lifesciences
- INVO Bioscience
- Kitazato USA
- Nidacon
- Rocket Medical
- Thermo Fisher Scientific
- Thomas Medical
- The American Fertility California Corp.
- Angels Creation Reproductive Center (ACRC)
- Aspire Houston Fertility Institute
- Boston IVF
- CARE Fertility
- Carolinas Fertility Institute
- CCRM Fertility
- Center of Reproductive Medicine
- Conceptions Reproductive Associates
- Dallas-Fort Worth Fertility Associates
- Extend Fertility
- Fertility Center
- Fertility Center of San Antonio
- Infertility Texas
- Innovative Fertility Center
- Institute for Human Reproduction (IHR)
- Kindbody
- Main Line Fertility & Reproductive Medicine
- Mayo Clinic
- New Hope Fertility Center
- Oma Fertility
- Overlake Reproductive Health
- Pacific Fertility Center
- Pacific Reproductive Center
- Reproductive Medicine Associates of Philadelphia
- ReproMed Fertility Center
- San Diego Fertility Center
- Santa Barbara Fertility Center
- Santa Monica Fertility
- Sher Institutes for Reproductive Medicine
- Southern California Reproductive Center (SCRC)
- Tennessee Reproductive Medicine (TRM)
- Texas Center for Reproductive Health
- The Center for Fertility and Gynecology
- The Fertility Center of Las Vegas
- The Reproductive Medicine Group
- UCLA Fertility and Reproductive Health Center
- Western Fertility Institute
- Wisconsin Fertility
1. The analysis of the U.S. Assisted Reproductive Technology market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the U.S. Assisted Reproductive Technology market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Assisted Reproductive Technology market.
Table of Contents
193 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY SERVICE
- 4.3.2 MARKET SEGMENTATION BY DEVICE
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 OVERVIEW OF INFERTILITY & ART
- 7.2 TRENDS IN ART
- 8 MARKET OPPORTUNITIES & TRENDS
- 8.1 GROWING NUMBER OF SINGLE PARENTS AND SAME-SEX COUPLES
- 8.2 TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN ART
- 8.3 RISING VENTURE CAPITAL & PRIVATE EQUITY INVESTMENTS IN INFERTILITY SERVICES
- 8.4 INCREASING FINANCIAL ASSISTANCE PROGRAMS & EMPLOYER BENEFITS FOR INFERTILITY TREATMENT
- 9 MARKET GROWTH ENABLERS
- 9.1 INCREASING PREVALENCE OF INFERTILITY
- 9.2 RISING NUMBER OF FERTILITY CLINICS OFFERING FERTILITY SERVICES
- 9.3 CHANGING LIFESTYLES OF PEOPLE
- 9.4 INCREASING ACCEPTANCE OF ART PROCEDURES
- 10 MARKET RESTRAINTS
- 10.1 HIGH COST OF INFERTILITY TREATMENT
- 10.2 RISKS AND LIMITATIONS ASSOCIATED WITH INFERTILITY TREATMENT
- 10.3 ETHICAL CHALLENGES RELATED TO INFERTILITY TREATMENT
- 10.4 LACK OF STANDARDIZED GOVERNMENT REGULATIONS ON INFERTILITY TREATMENT
- 11 MARKET LANDSCAPE
- 11.1 MARKET OVERVIEW
- 11.2 MARKET SIZE & FORECAST
- 11.2.1 TYPE INSIGHTS
- 11.2.2 SOURCE INSIGHTS
- 11.2.3 AGE GROUP INSIGHTS
- 11.2.4 TECHNIQUE INSIGHTS
- 11.2.5 PRODUCT INSIGHTS
- 11.2.6 END-USER INSIGHTS
- 11.3 FIVE FORCES ANALYSIS
- 11.3.1 THREAT OF NEW ENTRANTS
- 11.3.2 BARGAINING POWER OF SUPPLIERS
- 11.3.3 BARGAINING POWER OF BUYERS
- 11.3.4 THREAT OF SUBSTITUTES
- 11.3.5 COMPETITIVE RIVALRY
- 12 TYPE
- 12.1 MARKET SNAPSHOT & GROWTH ENGINE
- 12.2 MARKET OVERVIEW
- 13 SERVICES
- 13.1 MARKET OVERVIEW
- 13.2 MARKET SIZE & FORECAST
- 13.3 ART SERVICES MARKET BY SOURCE
- 13.3.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.4 FROZEN NON-DONOR
- 13.4.1 MARKET SIZE & FORECAST
- 13.5 FRESH NON-DONOR
- 13.5.1 MARKET SIZE & FORECAST
- 13.6 FRESH DONOR
- 13.6.1 MARKET SIZE & FORECAST
- 13.7 FROZEN DONOR
- 13.7.1 MARKET SIZE & FORECAST
- 13.8 ART SERVICES MARKET BY AGE GROUP
- 13.8.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.9 BETWEEN 35 & 40 YEARS
- 13.9.1 MARKET SIZE & FORECAST
- 13.10 LESS THAN 35 YEARS
- 13.10.1 MARKET SIZE & FORECAST
- 13.11 ABOVE 40 YEARS
- 13.11.1 MARKET SIZE & FORECAST
- 13.12 ART SERVICES MARKET BY TECHNIQUE
- 13.12.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.13 IN VITRO FERTILIZATION (IVF)
- 13.13.1 MARKET SIZE & FORECAST
- 13.14 FROZEN EMBRYO TRANSFER (FET)
- 13.14.1 MARKET SIZE & FORECAST
- 13.15 OTHERS
- 13.15.1 MARKET SIZE & FORECAST
- 14 DEVICES
- 14.1 MARKET OVERVIEW
- 14.2 MARKET SIZE & FORECAST
- 14.3 ART DEVICES MARKET BY PRODUCT
- 14.3.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.3.2 CONSUMABLES: MARKET SIZE & FORECAST
- 14.3.3 MEDIA: MARKET SIZE & FORECAST
- 14.3.4 EQUIPMENT: MARKET SIZE & FORECAST
- 14.4 ART DEVICES MARKET BY END-USER
- 14.4.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.4.2 FERTILITY CLINICS: MARKET SIZE & FORECAST
- 14.4.3 HOSPITALS: MARKET SIZE & FORECAST
- 15 COMPETITIVE LANDSCAPE
- 15.1 COMPETITION OVERVIEW: ART DEVICE MANUFACTURERS
- 15.2 COMPETITION OVERVIEW: SERVICE PROVIDERS
- 15.3 MARKET SHARE ANALYSIS: MANUFACTURERS
- 15.3.1 THE COOPER COMPANIES
- 15.3.2 COOK MEDICAL
- 15.3.3 VITROLIFE
- 15.3.4 FUJIFILM IRVINE SCIENTIFIC
- 15.3.5 ROCKET MEDICAL
- 15.3.6 KITAZATO
- 15.3.7 MERCK GROUP
- 15.3.8 HAMILTON THORNE
- 15.4 MARKET SHARE ANALYSIS: ART SERVICE PROVIDERS
- 16 KEY MANUFACTURER PROFILES
- 16.1 THE COOPER COMPANIES
- 16.1.1 BUSINESS OVERVIEW
- 16.1.2 MAJOR PRODUCT OFFERINGS
- 16.1.3 KEY STRENGTHS
- 16.1.4 KEY STRATEGIES
- 16.1.5 KEY OPPORTUNITIES
- 16.2 COOK MEDICAL
- 16.2.1 BUSINESS OVERVIEW
- 16.2.2 MAJOR PRODUCT OFFERINGS
- 16.2.3 KEY STRATEGIES
- 16.2.4 KEY STRENGTHS
- 16.2.5 KEY OPPORTUNITIES
- 16.3 FUJIFILM IRVINE SCIENTIFIC
- 16.3.1 BUSINESS OVERVIEW
- 16.3.2 MAJOR PRODUCT OFFERINGS
- 16.3.3 KEY STRATEGIES
- 16.3.4 KEY STRENGTHS
- 16.3.5 KEY OPPORTUNITIES
- 16.4 HAMILTON THORNE
- 16.4.1 BUSINESS OVERVIEW
- 16.4.2 MAJOR PRODUCT OFFERINGS
- 16.4.3 KEY STRATEGIES
- 16.4.4 KEY STRENGTHS
- 16.4.5 KEY OPPORTUNITIES
- 16.5 MERCK GROUP
- 16.5.1 BUSINESS OVERVIEW
- 16.5.2 MAJOR PRODUCT OFFERINGS
- 16.5.3 KEY STRATEGIES
- 16.5.4 KEY STRENGTHS
- 16.5.5 KEY OPPORTUNITIES
- 16.6 VITROLIFE
- 16.6.1 BUSINESS OVERVIEW
- 16.6.2 MAJOR PRODUCT OFFERINGS
- 16.6.3 KEY STRATEGIES
- 16.6.4 KEY STRENGTHS
- 16.6.5 KEY OPPORTUNITIES
- 17 OTHER PROMINENT MANUFACTURERS
- 17.1 CARL ZEISS
- 17.1.1 BUSINESS OVERVIEW
- 17.1.2 MAJOR PRODUCT OFFERINGS
- 17.2 ESCO LIFESCIENCES
- 17.2.1 BUSINESS OVERVIEW
- 17.2.2 MAJOR PRODUCT OFFERINGS
- 17.3 INVO BIOSCIENCE
- 17.3.1 BUSINESS OVERVIEW
- 17.3.2 MAJOR PRODUCT OFFERINGS
- 17.4 KITAZATO
- 17.4.1 BUSINESS OVERVIEW
- 17.4.2 MAJOR PRODUCT OFFERINGS
- 17.5 NIDACON
- 17.5.1 BUSINESS OVERVIEW
- 17.5.2 MAJOR PRODUCT OFFERINGS
- 17.6 ROCKET MEDICAL
- 17.6.1 BUSINESS OVERVIEW
- 17.6.2 MAJOR PRODUCT OFFERINGS
- 17.7 THERMO FISHER SCIENTIFIC
- 17.7.1 BUSINESS OVERVIEW
- 17.7.2 MAJOR PRODUCT OFFERINGS
- 17.8 THOMAS MEDICAL
- 17.8.1 BUSINESS OVERVIEW
- 17.8.2 MAJOR PRODUCT OFFERINGS
- 18 PROMINENT ART SERVICE PROVIDERS
- 18.1 THE AMERICAN FERTILITY CALIFORNIA CORP.
- 18.1.1 BUSINESS OVERVIEW
- 18.2 ANGELS CREATION REPRODUCTIVE CENTER
- 18.2.1 BUSINESS OVERVIEW
- 18.3 ASPIRE HOUSTON FERTILITY INSTITUTE
- 18.3.1 BUSINESS OVERVIEW
- 18.4 BOSTON IVF
- 18.4.1 BUSINESS OVERVIEW
- 18.5 CARE FERTILITY
- 18.5.1 BUSINESS OVERVIEW
- 18.6 CAROLINAS FERTILITY INSTITUTE
- 18.6.1 BUSINESS OVERVIEW
- 18.7 CCRM FERTILITY
- 18.7.1 BUSINESS OVERVIEW
- 18.8 CENTER OF REPRODUCTIVE MEDICINE
- 18.8.1 BUSINESS OVERVIEW
- 18.9 CONCEPTIONS REPRODUCTIVE ASSOCIATES
- 18.9.1 BUSINESS OVERVIEW
- 18.10 DALLAS-FORT WORTH FERTILITY ASSOCIATES
- 18.10.1 BUSINESS OVERVIEW
- 18.11 EXTEND FERTILITY
- 18.11.1 BUSINESS OVERVIEW
- 18.12 FERTILITY CENTER
- 18.12.1 BUSINESS OVERVIEW
- 18.13 FERTILITY CENTER OF SAN ANTONIO
- 18.13.1 BUSINESS OVERVIEW
- 18.14 INFERTILITY TEXAS
- 18.14.1 BUSINESS OVERVIEW
- 18.15 INNOVATIVE FERTILITY CENTER
- 18.15.1 BUSINESS OVERVIEW
- 18.16 INSTITUTE FOR HUMAN REPRODUCTION
- 18.16.1 BUSINESS OVERVIEW
- 18.17 KINDBODY
- 18.17.1 BUSINESS OVERVIEW
- 18.18 MAIN LINE FERTILITY & REPRODUCTIVE MEDICINE
- 18.18.1 BUSINESS OVERVIEW
- 18.19 MAYO CLINIC
- 18.19.1 BUSINESS OVERVIEW
- 18.20 NEW HOPE FERTILITY CENTER
- 18.20.1 BUSINESS OVERVIEW
- 18.21 OMA FERTILITY
- 18.21.1 BUSINESS OVERVIEW
- 18.22 OVERLAKE REPRODUCTIVE HEALTH
- 18.22.1 BUSINESS OVERVIEW
- 18.23 PACIFIC FERTILITY CENTER
- 18.23.1 BUSINESS OVERVIEW
- 18.24 PACIFIC REPRODUCTIVE CENTER
- 18.24.1 BUSINESS OVERVIEW
- 18.25 REPRODUCTIVE MEDICINE ASSOCIATES OF PHILADELPHIA
- 18.25.1 BUSINESS OVERVIEW
- 18.26 REPROMED FERTILITY CENTER
- 18.26.1 BUSINESS OVERVIEW
- 18.27 SAN DIEGO FERTILITY
- 18.27.1 BUSINESS OVERVIEW
- 18.28 SANTA BARBARA FERTILITY CENTER
- 18.28.1 BUSINESS OVERVIEW
- 18.29 SANTA MONICA FERTILITY
- 18.29.1 BUSINESS OVERVIEW
- 18.30 SHER INSTITUTES FOR REPRODUCTIVE MEDICINE
- 18.30.1 BUSINESS OVERVIEW
- 18.31 SOUTHERN CALIFORNIA REPRODUCTIVE CENTER
- 18.31.1 BUSINESS OVERVIEW
- 18.32 TENNESSEE REPRODUCTIVE MEDICINE
- 18.32.1 BUSINESS OVERVIEW
- 18.33 TEXAS CENTER FOR REPRODUCTIVE HEALTH
- 18.33.1 BUSINESS OVERVIEW
- 18.34 THE CENTER FOR FERTILITY AND GYNECOLOGY
- 18.34.1 BUSINESS OVERVIEW
- 18.35 THE FERTILITY CENTER OF LAS VEGAS
- 18.35.1 BUSINESS OVERVIEW
- 18.36 THE REPRODUCTIVE MEDICINE GROUP
- 18.36.1 BUSINESS OVERVIEW
- 18.37 UCLA HEALTH
- 18.37.1 BUSINESS OVERVIEW
- 18.38 WESTERN FERTILITY INSTITUTE
- 18.38.1 BUSINESS OVERVIEW
- 18.39 WISCONSIN FERTILITY INSTITUTE
- 18.39.1 BUSINESS OVERVIEW
- 19 REPORT SUMMARY
- 19.1 KEY TAKEAWAYS
- 19.2 STRATEGIC RECOMMENDATIONS
- 20 QUANTITATIVE SUMMARY
- 20.1 MARKET BY TYPE
- 20.2 MARKET BY ART SERVICES
- 20.2.1 ART SERVICES: SOURCE SEGMENTATION
- 20.2.2 ART SERVICES: AGE GROUP SEGMENTATION
- 20.2.3 ART SERVICES: TECHNIQUE SEGMENTATION
- 20.3 MARKET BY ART DEVICES
- 20.3.1 ART DEVICES: PRODUCT SEGMENTATION
- 20.3.2 ART DEVICES: END-USER SEGMENTATION
- 21 APPENDIX
- 21.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.